This model offers a valuable platform to investigate early tauopathy mechanisms and their progression, providing insights into the temporal dynamics of tau pathology that precede cognitive symptoms in Alzheimer’s disease and related disorders. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.